Newscen Biopharm Co., Limited is a professional manufacturer of in
vitro diagnostic products and related supporting apparatuses, which
is jointly founded by Tianjin Pharmaceutical Group, Tianjin
Zhongxin Pharmaceuticals Co., Ltd and oversea Chinese
entrepreneurs.
Founded in 2003, the company is one national high tech corporation
and Tianjin Grade A medical device manufacturer. Over the years,
the company has been committed to the research, development,
production and sales of in vitro diagnostic products and related
supporting apparatuses, and also has provided OEM and ODM and technology transfer and cooperation as well as some other
customer market based diversified services to customers at home and
abroad.
NewScen is based on independent innovation and relies on the talent
sharing at home and abroad, information interaction advantage,
antibody preparation and new product R & D technology platform to
develop and produce nine series about one hundred kinds of products
including tests and instruments and put on the market in
succession.
HIV (1 + 2) antibody rapid test Kit and other IVD (In Vitro
Diagnostic) devices obtained National Patent and National Class of New Drug Certificate; HCV Antibody Rapid Test is the first double antigen sandwich test
HCV patented product; NewScen’s quantitative test broke through the
technical difficulty of the colloid gold quantitative detection,
opening up a new situation for clinical application of Colloidal
Gold test. Rapid immuno assay reader provides an open and common
platform for qualitative and quantitative detection of the
Colloidal Gold test.
The company has received CFDA medical device certificates of 32 products, 49 independent Intellectual Property Rights, FDA certificates of series of products and European CE certificates of 16 products. Production management is in strict
accordance with the regulations of in vitro diagnostic product
production as well as international quality management system (ISO 9001, ISO 13485) so as to ensure high product quality. Products are sold throughout
the country and in North America, South America, Southeast Asia,
Europe, the Middle East, Africa and other international markets.
Currently, the company integrated Colloidal Gold test,
immunochromatographic interpretoscope and cloud technology and
other technical advantages, and created management integrated POCT
system, so as to achieve convenient, accurate and efficient onsite
data collection and remote guidance or data sharing of the
monitoring center and promote the development of modern testing
technique and the improvement of diagnosis and treatment level.
NewScen has obtained the project support from Tianjin or the
country for nine times in succession, has been identified as one
Hightech Enterprise in Tianjin, has obtained the title of “Top 100 Enterprise in Tianjin” among Tianjin SMEs, and is the rapid diagnostic Hightech
demonstration project base and National 863 Project undertaker
awarded by the NDRC (National Development and Reform Commission).
Fecal Occult Blood, Serum Ferritin and Hepatitis C rapid test
products were named Tianjin independent innovation products; brand
“YBT”products have been awarded the title of “Chinese Women and Children Favorite Brand Product” by Chinese Women and Children Development Center; “YBT” trademark was named “Tianjin Famous Trademark”.
“Honesty, Verity, Authenticity, and Innovation", is our persistent commitment.
“Encouraging Our Employees Growing With Company” is the driving force beneath our surging growth.
